Role of heterocycles in inhibition of VEGFR-2 – a recent update (2019–2022)

Dorababu, Atukuri

doi:10.1039/d3md00506b

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

2025

Publication Types

Select...

Article2

Preprint1

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

References 90 publications

(102 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

Benzofuran‐Chalcone Derivatives as VEGFR‐2 Inhibitors: Synthesis and Anticancer Evaluation

Liu,

Zhang,

Zhang

et al. 2024

Chemistry & Biodiversity

View full text Add to dashboard Cite

The discovery and development of efficient VEGFR‐2 inhibitors has become a research hotspot in cancer treatment. In this work, a series of new benzofuran‐based chalcone derivatives have been prepared, and in vitro anticancer activities have been evaluated. The results revealed that derivatives showed selective cytotoxic activity against HCC1806, Hela and A549 cell lines, especially 5c exhibited excellent inhibitory effect on VEFGR‐2 (IC50 = 1.07 nM). The molecular docking study indicated that 5c had an obvious binding site with the target VEGFR‐2 (PDB ID: 4BSK). Therefore, the benzofuran‐based chalcone derivatives could be potent VEGFR‐2 inhibitors.

show abstract